Wenxuan Zeng

机构：Sun Yat-sen University, Xiamen University, Peking University, Innovation Team (China), Wuhan Institute of Technology · ORCID：0000-0003-3743-0947

发表论文 47 篇 · 总被引 295 次 · h-index 9

代表论文

• A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy (2025 · Nature Communications · 被引 80)
• Total saponin extracts of Pseudostellaria heterophylla ameliorates meibomian gland dysfunction through SCD1/SPT1/ceramide axis (2025 · Journal of Ethnopharmacology · 被引 7)
• Design of a bispecific peptide-nanozyme conjugate for cancer immunotherapy (2026 · Cell Reports Medicine · 被引 4)
• UniCAIM: A Unified CAM/CIM Architecture with Static-Dynamic KV Cache Pruning for Efficient Long-Context LLM Inference (2025 · 被引 3)
• Targeted Drug Delivery for Precision Mitochondrial Therapy in Osteoporosis: Therapeutic Strategies and Advances (2024 · Current Drug Therapy · 被引 3)
• An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy (2026 · Journal of the American Chemical Society · 被引 2)